Skip to content
Society

European Hospitals Face Superbug Threat With Mortality Rates Reaching Seventy Percent

Croatia News Editorial team · · Reading time 10min read · Views 0 ·
Key — European hospitals face a growing threat from antibiotic-resistant superbugs with mortality rates reaching up to 70 percent.

European hospitals face a growing threat from antibiotic-resistant superbugs, with mortality rates reaching up to 70 percent according to the European Centre for Disease Prevention and Control. The specific bacterium causing concern is Klebsiella pneumoniae, which has shown alarming resistance to multiple antibiotics. The European Union aims to reduce the rate of such infections by 5 percent by 2030 to combat this escalating public health crisis.

Antibiotic Resistance Threat

The incidence of bloodstream infections caused by this resistant bacterium increased by 72 percent between 2019 and 2025. Some strains of Klebsiella pneumoniae have developed resistance to nearly all antibiotics, including newer drugs. Kristian Giske, a specialist at the European Centre for Disease Prevention and Control, stated that the resistance of Klebsiella to drugs is the most worrying finding from the past year among all collected data.

Mortality rates for infections caused by this bacterium typically range between 40 percent and 70 percent. Antimicrobial resistance is projected to cause approximately 35,000 deaths annually across the European Union, Iceland, and Norway. The European Centre for Disease Prevention and Control emphasizes that strict infection control measures, such as hand hygiene and proper use of personal protective equipment, are necessary to curb the spread.

Health Impact Statistics

Klebsiella pneumoniae is an intestinal bacterium, which may introduce additional reservoirs for transmission within the human body. The European Union is currently behind its 2030 targets for reducing these infections. This situation highlights significant challenges in maintaining public health standards across the continent.

The European Centre for Disease Prevention and Control has issued warnings regarding the spread of antibiotic-resistant superbugs in European hospitals. The growing threat demands immediate and coordinated international responses from health authorities and medical professionals to protect vulnerable populations.

Future Policy Developments

A new pharmaceutical law is expected to be signed in December to encourage the development of new antibiotics through market incentives and stable payment models. This legislative action aims to support pharmaceutical innovation in the face of growing antimicrobial resistance challenges. Health organizations are closely monitoring these developments to ensure effective implementation.

The European Centre for Disease Prevention and Control continues to monitor infection rates closely across member states. The ongoing efforts involve strengthening surveillance systems and improving clinical practices to manage the spread of resistant organisms effectively. International cooperation remains critical to mitigating the severe health risks posed by these superbugs.

Glossary

  • European Union — The European Union is a political and economic union of member states. It aims to reduce the rate of certain infections by 5 percent by 2030. The European Union is currently behind its 2030 targets for reducing these infections.
  • Member states — The European Centre for Disease Prevention and Control continues to monitor infection rates closely across member states. The ongoing efforts involve strengthening surveillance systems and improving clinical practices to manage the spread of resistant organisms effectively. International cooperation remains critical to mitigating the severe health risks posed by these superbugs.
  • European Centre for Disease Prevention and Control — The European Centre for Disease Prevention and Control (ECDC) is an agency of the European Union (EU) whose mission is to strengthen Europe's defences against infectious diseases. It covers a wide spectrum of activities, such as surveillance, epidemic intelligence, response, scientific advice, microbiology, preparedness, public health training, international relations, health communication, and the scientific journal Eurosurveillance.
  • Klebsiella pneumoniae — Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria are a group of emerging highly drug-resistant Gram-negative bacilli causing infections associated with significant morbidity and mortality. Klebsiella pneumoniae includes numerous mechanisms for antibiotic resistance, many of which are located on highly mobile genetic elements.

This article was written with AI assistance from multiple news reports and is reviewed by our editors under our editorial principles. Editorial Standards · Tips & Contact

How did you like this post?

Comments 0

Be the first to comment

Contact us

← Croatia News Home
Croatia News Get new posts by emailSubscribe to receive new content via email. Unsubscribe anytime.
Was this helpful?Share it with friends & social